Cargando…
Disulfiram, a drug widely used to control alcoholism, suppresses self-renewal of glioblastoma and overrides resistance to temozolomide
Glioblastomas (GBM) are associated with high rates of relapse. These brain tumors are often resistant to chemotherapies like temozolomide (TMZ) and there are very few treatment options available to patients. We recently reported that polo-like kinase-1 (PLK1) is associated with the proliferative sub...
Autores principales: | Triscott, Joanna, Lee, Cathy, Hu, Kaiji, Fotovati, Abbas, Berns, Rachel, Pambid, Mary, Luk, Margaret, Kast, Richard E., Kong, Esther, Toyota, Eric, Yip, Stephen, Toyota, Brian, Dunn, Sandra E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717961/ https://www.ncbi.nlm.nih.gov/pubmed/23047041 |
Ejemplares similares
-
High-Throughput Chemical Screens Identify Disulfiram as an Inhibitor of Human Glioblastoma Stem Cells
por: Hothi, Parvinder, et al.
Publicado: (2012) -
CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide
por: Kast, Richard E., et al.
Publicado: (2014) -
The role of interleukin-18 in glioblastoma pathology implies therapeutic potential of two old drugs—disulfiram and ritonavir
por: Kast, Richard E
Publicado: (2015) -
Small interfering RNA library screen identified polo-like kinase-1 (PLK1) as a potential therapeutic target for breast cancer that uniquely eliminates tumor-initiating cells
por: Hu, Kaiji, et al.
Publicado: (2012) -
Oxidizing to death: Disulfiram for cancer cell killing
por: Brüning, Ansgar, et al.
Publicado: (2014)